Argentina reaches more than 92 million vaccines applied

The country seems to be close to overcoming the third wave of the coronavirus, and in the midst of it, it is advancing positively with its vaccination plan, since 92,275,649 have been applied to date. vaccines.

In this sense, 40,197,226 people received the biological to start their immunization, while 36,057,523 Argentines completed their vaccination schedule. Buenos Aires is the province that most vaccines has administered.

The country will start producing its own vaccine.

In addition, 12,981,098 third doses have been applied or vaccines nationwide boosterwhile the administration of the fourth dose will begin in March, mainly with the population at risk.

In addition to Buenos Aires, Córdoba and Santa Fe, they also lead the ranking in the number of doses applied, with 3,760,450 and 3,536,418, respectively, so the invitation from the authorities is to receive the vaccine.

The health pass is required in some social activities.

This also if it is considered that from today the schools will return to full attendance, where in some districts the health pass will be required as a requirement to enter the classrooms.

How is the application of vaccines worldwide

In the world, 10,865,562,222 doses have been applied, of which 768,621,262 correspond to Latin America. However, countries such as China, India and the United States are the ones that have made the most progress with inoculation.

At the population level, CABA is where the most vaccines have been applied.

According to the population density that has completed its vaccination schedule, Worldwide, Argentina ranks 26th with 79.46% of its population vaccinated with two doses..

While with the application of biological booster or third dose, the country is further behind, since the list is led by Malta, with 79.94% of its population vaccinated, followed by Chile with 74.25% and Iceland with 73.74%.

The vaccine is effective against variants of the coronavirus.

In total, 99,112,630 doses have been distributed in Argentina, mainly from Sinopharm, Pfizer, Moderna, Astrazeneca, Covishield, and Sputnik, from the United States, China, Russia, India, and the United Kingdom.

Source link